|
Wednesday 1st July 2020 |
Text too small? |
AFT Pharmaceuticals Limited (NZX: AFT /ASX:AFP) (AFT) announced today that its NZ$2 million share purchase plan (SPP) has closed oversubscribed. The SPP received strong shareholder support with AFT receiving applications totalling approximately NZ$9.8 million. Applications will be scaled on a proportionate basis in accordance with the number of AFT shares held by applicants on the SPP record date (9 June 2020). Refunds of surplus application amounts paid will be made to applicants in accordance with the terms of the SPP offer document. See link below for detail.
No comments yet
October 29th Morning Report
POT completes sale of Rolleston property asset
RAD - Radius Health to Release 1H27 Results on 11 November 2026
PCT Climate Related Disclosures 2026
SPN confirms FY26 result & provides leadership update
AGL - Accordant Group FY27 Half Year results
AIR - Air NZ to hold investor update
NZM - NZME receives offer for renewal of radio spectrum licences
October 28th Morning Report
ARG - FY27 interim results announcement date and webcast details